Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 17, Issue 4, 1999, Pages 1185-1193

  Thomas, Michael ^a   Rübe, Christian ^a   Semik, Michael ^a   Von Eiff, Michael ^a   Freitag, Lutz ^a   Macha, Hans N ^a   Wagner, Wolfgang ^a   Klinke, Folker ^a   Scheld, Hans H ^a   Willich, Norman ^a   Berdel, Wolfgang E ^a   Junker, Klaus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; VINDESINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SURVIVAL TIME; THORACOTOMY; TREATMENT OUTCOME; TUMOR REGRESSION;

EID: 0345628588     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.4.1185     Document Type: Article

References (23)

1. Mountain CF: A new international staging system for lung cancer. Chest 89:225-233, 1986 (suppl 4)
2. Mountain CF: Prognostic implications of the International Staging System for Lung Cancer. Semin Oncol 15:236-245, 1988
3. Johnson DH, Turrisi AT, Pass HI: Combined modality treatment for locally advanced non-small-cell lung cancer, in Pass HI, Micthell JB, Johnson DH, Turrisi AT (eds): Lung Cancer: Principles and Practice (ed 1). New York, NY, Lippincott-Raven, 1996, pp 863-873
4. Vokes EE: Interactions of chemotherapy and radiation. Semin Oncol 20:70-79, 1993
5. Saunders MI: Radiotherapeutic techniques for lung cancer: Accelerated hyperfractionation, in Pass HI, Micthell JB, Johnson DH, Turrisi AT (eds): Lung Cancer: Principles and Practice (ed 1). New York, NY, Lippincott-Raven, 1996, pp 721-727
6. Bartelink H, Begg AC, Dewit C, et al: Combined treatment with radiation and anti-cancer drugs: Experimental and clinical results, in Lehen N (ed): Radiobiology in Radiotherapy. Berlin, Germany, Springer, 1987, pp 177-199
7. Albain KS: Induction therapy followed by definitive local control for stage III non-small-cell lung cancer: A review, with a focus on recent trimodality trials. Chest 102:43-50, 1993 (suppl.)
8. O'Hara JA, Douple EB, Richmond RC: Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 Cells. Int J Radiat Oncol Biol Phys 12:1419-1422, 1986
9. Skov K, McPhail S: Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: A comparison of cisplatin, carboplatin, iproplatin, and tetraplatin. Int J Radiat Oncol Biol Phys 20:221-225, 1991
10. Balla I, Michel C, Fritz-Niggle H: Synergistic interaction between vindesine and x-rays in the prenatal development of mice. Int J Radiat Biol 52:373-383, 1987
11. Green S, Weiss GR: Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 10:293-253, 1992
12. Junker K, Thomas M, Schulmann K, et al: Tumor regression in non-small-cell lung cancer following neoadjuvant therapy: Histological assessment. J Cancer Res Clin Oncol 123:469-477, 1997
13. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
14. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977
15. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34:187-220, 1972
16. Recine D, Rowland K, Reddy S, et al: Combined modality therapy for locally advanced non-small-cell lung carcinoma. Cancer 66:2270-2278, 1990
17. Weiden PL, Piantadosi S: Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: A phase II study of the lung cancer study group. J Natl Cancer Inst 83:266-272, 1991
18. Albain KS, Rusch VW, Crowley JJ, et al: Concurrent cisplatin/ etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13:1880-1892, 1995
19. Choi NC, Carey RW, Daly W, et al: Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 15:712-722, 1997
20. Eberhardt W, Wilke H, Stamatis G, et al: Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial. J Clin Oncol 16:622-634, 1998
21. Pisters KMW, Kris MG, Gralla RJ, et al: Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: Implications for the design of future non-small-cell lung cancer combined modality trials. J Clin Oncol 11:1757-1762, 1993
22. Fowler WC, Langer CJ, Curran WJ, et al: Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55:986-989, 1993
23. Fleck J, Camargo J, Godoy D, et al: Chemoradiation therapy versus chemotherapy alone as a neoadjuvant treatment for stage III non-small-cell lung cancer: Preliminary report of a phase III prospective randomized trial. Proc Am Soc Clin Oncol 12:333, 1993 (abstr 1108)